Abstract:In order to investigate the occurrence of chronic hepatitis B virus(HBV) infection in HB vaccine inoculated infants born to HBsAg positive mothers and its affecting factors and also to study the effect of combined use of HB immunoglobulin (HBIG) and HB vaccine on the blocking of perinatal transmission of HBV, we divided 624 infants born to HBsAg positive mothers into two groups randomly. The first group of infants were simply vaccinated with HB vaccine 20μg at,0, 1, 6 months old. The second group of infants were inoculated with HBIG 100 IU at their birth and further vaccinated with HB vaccine 20μg at 1,2,7 months old. The HBsAg of the two groups of infants was tested at the age of 1,3,6,12,18,24 months old and every year by EIA. They were all followed up for 6.34±1.71 years averagely. The follow-up results showed that there were 89 childeren infected chronically by HBV, among them 82% appeared to be HBsAg positive, firstly seen before the age of 6 months mainly attributing to uterus infection. The HBV chronic infection rate of infants born to HBsAg, HBeAg positive mothers (HB vaccine immunized, 24.5%; HBIG+HB vaccine, 10.6%, P<0.005) was higher than that of infants born to HBsAg positive mothers (HB vaccine immunized, 10.7%; HBIG+HB vaccine 3.8%, P<0.025). Moreover, the chronicity rate of the infants whose HBsAg firstly appeared within 6　　months and were born to HBsAg, HBeAg positive mothers was higher than that of the infants born to HBsAg positive months (68%,40% respertively in HB vaccine inoculated group, P<0.025). Infants immunized combinely with HBIG and HB vaccine had their chronic HBV infection decreased from 17.6% to 5.0% at l year old as compared with that of HB vaccine inoculated infants. The total chronic HBV infection rate in children born to HBsAg, HBeAg positive mothers decreased from 24.5% to 10.6% (P<0.005) and that in children born to HBsAg positive mothers decreased from 10.7% to 3.8% (P<0.025). The HBV chronicity rate of HBsAg positive infants born to HBsAg, HBeAg positive mothers also decreased and that of infants born with HBsAg negative, but became positive after 1-6 months decreased from 40.9% to 0% (P=0.0315). The HBsAg seronegative conversion rate in l month old infants born to HBsAg positive mothers increased from 26.4% to 58.8% (P<0.025). All these data indicated that infants born to HBsAg positive mothers, though had been HB vaccine immunized, still had chronic infection, that was chiefly due to chronic uterus infection by HBV. The single use of HB vaccine can not completely block the uterus infection of HBV, but when combinatively used with HBIG, the blocking effect is more efficient, the chronicity of HBV infection also can be avoided.

HBsAg-positive and HBsAg-negative hepatitis B virus 1 infection among mother-teenager pairs 13 years after 2 neonatal hepatitis B vaccination 3

Hepatitis B Virus Surface Antigen (Hbsag)-Positive and HBsAg-negative Hepatitis B Virus Infection among Mother-Teenager Pairs 13 Years after Neonatal Hepatitis B Virus Vaccination.

Application of hepatitis B immunoglobulin in prevention of mother-to-child transmission of chronic hepatitis B in HBsAg- and HBeAg-positive mother

A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.

Overt and occult hepatitis B infection after neonatal vaccination: mother-to-infant transmission and HBV vaccine effectiveness

Immune Response to Hepatitis B Vaccine in Children Born to HBsAg Positive Mothers: a Meta-Regression Analysis

Chronic hepatitis B infection in adolescents who received primary infantile vaccination

Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates

Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.

A Long-term Follow-up of Hepatitis B Vaccine Inoculated and HB Immunoglobulin Combinely Immunized Infants Born to HBsAg Positive Mothers

No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg

Reduced Mother-to-Child Transmission of Hepatitis B after Implementation of Completely Charge-Free Immunoprophylaxis in Mainland China

Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates

Efficacy of the Hepatitis B Vaccine Alone in the Prevention of Hepatitis B Perinatal Transmission in Infants Born to Hepatitis B E Antigen-Negative Carrier Mothers.

Transplacentally Acquired Maternal Antibody Against Hepatitis B Surface Antigen in Infants and Its Influence on the Response to Hepatitis B Vaccine.

Long-term Protection of Infants Against Hepatitis B by Neonatal Immunoprophylaxis Born from Mothers Infected with Hepatitis B Virus

Effect of neonatal immunoprophylaxis in mother-to-fetus transmission of HBV and analysis on risk factors for transmission

Real-world Efficacy of Immunoprophylaxis Against Mother-to-infant Transmission of Hepatitis B Virus Based on Puerperant Population

Efficacy and related factors of hepatitis B immunoglobulin and hepatitis B vaccination in blocking mother-to-child transmission of HBV among 377 children

Reduced Mother-to-child Transmission of Hepatitis B after Implementation of Completely Charge-Free Active-Passive Immunoprophylaxis: an Observational Cohort Study.

Influencing factors of high immune response in newborns induced by hepatitis B vaccine in Haidian District, Beijing